Topiramate Capsule, Extended Release
Product Images NDC 27241-296

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 27241-296). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg (Topiramate 100mg)

Label for Topiramate Extended-Release Capsules, USP 100 mg, 30 count, by Ajanta Pharma USA Inc. The label includes dosing instructions, storage conditions, child-resistant packaging warning, and directions for pharmacists to dispense a medication guide. The product is marked for once-daily oral administration and is made in India.*

FDA Label Image

150mg (Topiramate 150mg)

Label for Topiramate Extended-Release Capsules, USP 150 mg, in a 30-capsule bottle. The label advises once-daily dosing and includes pharmacist dispensing instructions. It is marketed by Ajanta Pharma USA Inc., made in India. The label also provides storage conditions and child-resistant packaging information, along with a barcode and space for lot and expiration dates.*

FDA Label Image

200mg (Topiramate 200mg)

Topiramate Extended-Release Capsules, USP 200 mg oral dosage form label. The label states once-daily dosing, contains 30 capsules, and is marketed by Ajanta Pharma USA Inc. Storage and child safety information is provided. The label includes an NDC barcode and notes that the product is RX only.*

FDA Label Image

25mg (Topiramate 25mg)

Label for Topiramate Extended-Release Capsules, USP 25 mg, once-daily dosing, containing 30 capsules. The label includes storage instructions, child-resistant packaging warning, and directs pharmacists to dispense the medication guide. Marketed by Ajanta Pharma USA Inc., made in India.*

FDA Label Image

50mg (Topiramate 50mg)

Label for Topiramate 50 mg extended-release capsules, USP, in a bottle containing 30 capsules. The label indicates once-daily dosing and is marketed by Ajanta Pharma USA Inc. Storage instructions include keeping the capsules in a tight container at 20° to 25°C, with excursions permitted to 15° to 30°C, and protecting from moisture. The package is child-resistant and for oral use.*

FDA Label Image

Figure1 (Topiramate Figure1)

A line graph showing cumulative rates of time to first seizure over approximately 500 days, comparing Topiramate 50 mg/day and Topiramate 400 mg/day. The graph displays two curves with distinct patterns indicating different seizure incidence rates over time for each dosage group.*

FDA Label Image

Figure2 (Topiramate Figure2)

A bar chart comparing the proportion of patients achieving various percentages of reduction in seizure frequency from baseline between placebo and Topiramate 200 mg/day groups. The x-axis shows reduction in seizure frequency ranges (Worse, 0 to <25%, 25 to <50%, 50 to <75%, 75 to 100%), and the y-axis shows the proportion of patients in percentage.*

FDA Label Image

Figure3 (Topiramate Figure3)

A bar chart comparing the change from baseline to double-blind phase I in average monthly migraine rates with standard error across different doses of Topiramate (50 mg/day, 100 mg/day, 200 mg/day) versus placebo. The chart presents data from two studies, Study 11 and Study 12, with sample sizes indicated for each dose group. Statistical significance is marked for certain doses.*

FDA Label Image

Structure (Topiramate Structure)

Chemical structure of Topiramate, displaying its molecular arrangement with characteristic sulfonamide and cyclic ether groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.